• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化暴发环境下一剂和两剂霍乱疫苗的分配:建模研究。

Optimizing one-dose and two-dose cholera vaccine allocation in outbreak settings: A modeling study.

机构信息

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.

School of Interdisciplinary Arts and Sciences, University of Washington, Tacoma, Washington, United States of America.

出版信息

PLoS Negl Trop Dis. 2022 Apr 20;16(4):e0010358. doi: 10.1371/journal.pntd.0010358. eCollection 2022 Apr.

DOI:10.1371/journal.pntd.0010358
PMID:35442958
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9060364/
Abstract

BACKGROUND

A global stockpile of oral cholera vaccine (OCV) was established in 2013 for use in outbreak response and are licensed as two-dose regimens. Vaccine availability, however, remains limited. Previous studies have found that a single dose of OCV may provide substantial protection against cholera.

METHODS

Using a mathematical model with two age groups paired with optimization algorithms, we determine the optimal vaccination strategy with one and two doses of vaccine to minimize cumulative overall infections, symptomatic infections, and deaths. We explore counterfactual vaccination scenarios in three distinct settings: Maela, the largest refugee camp in Thailand, with high in- and out-migration; N'Djamena, Chad, a densely populated region; and Haiti, where departments are connected by rivers and roads.

RESULTS

Over the short term under limited vaccine supply, the optimal strategies for all objectives prioritize one dose to the older age group (over five years old), irrespective of setting and level of vaccination coverage. As more vaccine becomes available, it is optimal to administer a second dose for long-term protection. With enough vaccine to cover the whole population with one dose, the optimal strategies can avert up to 30% to 90% of deaths and 36% to 92% of symptomatic infections across the three settings over one year. The one-dose optimal strategies can avert 1.2 to 1.8 times as many cases and deaths compared to the standard two-dose strategy.

CONCLUSIONS

In an outbreak setting, speedy vaccination campaigns with a single dose of OCV is likely to avert more cases and deaths than a two-dose pro-rata campaign under a limited vaccine supply.

摘要

背景

2013 年建立了全球口服霍乱疫苗(OCV)储备库,用于应对疫情爆发,并获得了两剂方案的许可。然而,疫苗的供应仍然有限。先前的研究发现,一剂 OCV 可能对霍乱提供实质性保护。

方法

我们使用具有两个年龄组的数学模型和优化算法,确定使用一剂和两剂疫苗的最佳接种策略,以最大限度地减少累计总感染、有症状感染和死亡人数。我们在三个不同环境中探索了假设性的接种情景:泰国最大的难民营迈拉(Maela),移民输入和输出都很高;乍得的恩贾梅纳(N'Djamena),人口密集地区;以及海地,那里的行政区由河流和道路相连。

结果

在短期内疫苗供应有限的情况下,所有目标的最佳策略都是优先为年龄较大的群体(五岁以上)接种一剂疫苗,无论环境和接种覆盖率如何。随着疫苗供应的增加,长期保护的最佳策略是接种第二剂。如果有足够的疫苗为所有人接种一剂,最佳策略可以在一年内避免三个环境中高达 30%至 90%的死亡和 36%至 92%的有症状感染。一剂最佳策略可以避免 1.2 到 1.8 倍的病例和死亡,而标准的两剂按比例分配策略。

结论

在疫情爆发的情况下,与在有限的疫苗供应下进行两剂按比例分配的疫苗接种运动相比,快速的单剂 OCV 疫苗接种运动可能会避免更多的病例和死亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6276/9060364/84496e7c619e/pntd.0010358.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6276/9060364/5c8fc521baec/pntd.0010358.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6276/9060364/f8d6f1a7198b/pntd.0010358.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6276/9060364/2019e0262526/pntd.0010358.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6276/9060364/cb2542e0bf89/pntd.0010358.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6276/9060364/e1d03d342171/pntd.0010358.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6276/9060364/84496e7c619e/pntd.0010358.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6276/9060364/5c8fc521baec/pntd.0010358.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6276/9060364/f8d6f1a7198b/pntd.0010358.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6276/9060364/2019e0262526/pntd.0010358.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6276/9060364/cb2542e0bf89/pntd.0010358.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6276/9060364/e1d03d342171/pntd.0010358.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6276/9060364/84496e7c619e/pntd.0010358.g006.jpg

相似文献

1
Optimizing one-dose and two-dose cholera vaccine allocation in outbreak settings: A modeling study.优化暴发环境下一剂和两剂霍乱疫苗的分配:建模研究。
PLoS Negl Trop Dis. 2022 Apr 20;16(4):e0010358. doi: 10.1371/journal.pntd.0010358. eCollection 2022 Apr.
2
The Impact of a One-Dose versus Two-Dose Oral Cholera Vaccine Regimen in Outbreak Settings: A Modeling Study.单剂量与双剂量口服霍乱疫苗接种方案在疫情环境中的影响:一项建模研究
PLoS Med. 2015 Aug 25;12(8):e1001867. doi: 10.1371/journal.pmed.1001867. eCollection 2015 Aug.
3
Comparing alternative cholera vaccination strategies in Maela refugee camp: using a transmission model in public health practice.比较 Maela 难民营中替代霍乱疫苗接种策略:在公共卫生实践中使用传播模型。
BMC Infect Dis. 2019 Dec 21;19(1):1075. doi: 10.1186/s12879-019-4688-6.
4
Mass vaccination with a two-dose oral cholera vaccine in a long-standing refugee camp, Thailand.在泰国一个长期存在的难民营中大规模接种两剂口服霍乱疫苗。
Vaccine. 2016 Jan 2;34(1):128-33. doi: 10.1016/j.vaccine.2015.10.112. Epub 2015 Nov 6.
5
Comprehensive Review on the Use of Oral Cholera Vaccine (OCV) in Ethiopia: 2019 to 2023.埃塞俄比亚口服霍乱疫苗(OCV)使用情况的综合综述:2019 年至 2023 年。
Clin Infect Dis. 2024 Jul 12;79(Supplement_1):S20-S32. doi: 10.1093/cid/ciae194.
6
Neighborhood-targeted and case-triggered use of a single dose of oral cholera vaccine in an urban setting: Feasibility and vaccine coverage.在城市环境中以社区为目标并基于病例触发使用单剂量口服霍乱疫苗:可行性和疫苗覆盖率
PLoS Negl Trop Dis. 2017 Jun 8;11(6):e0005652. doi: 10.1371/journal.pntd.0005652. eCollection 2017 Jun.
7
Oral cholera vaccination coverage after the first global stockpile deployment in Haiti, 2014.海地 2014 年首次全球库存部署后口服霍乱疫苗的接种率。
Vaccine. 2019 Oct 8;37(43):6348-6355. doi: 10.1016/j.vaccine.2019.09.018. Epub 2019 Sep 11.
8
Achieving coordinated national immunity and cholera elimination in Haiti through vaccination: a modelling study.通过疫苗接种实现海地全国免疫协调和消除霍乱:建模研究。
Lancet Glob Health. 2020 Aug;8(8):e1081-e1089. doi: 10.1016/S2214-109X(20)30310-7.
9
Optimal allocation of the limited oral cholera vaccine supply between endemic and epidemic settings.在地方流行地区和疫情地区之间对有限的口服霍乱疫苗供应进行优化分配。
J R Soc Interface. 2015 Oct 6;12(111):20150703. doi: 10.1098/rsif.2015.0703.
10
Long-term effectiveness of one and two doses of a killed, bivalent, whole-cell oral cholera vaccine in Haiti: an extended case-control study.海地一剂和两剂口服灭活、二价、全细胞霍乱疫苗的长期效果:一项扩展病例对照研究。
Lancet Glob Health. 2018 Sep;6(9):e1028-e1035. doi: 10.1016/S2214-109X(18)30284-5.

引用本文的文献

1
Allocation of Oral Cholera Vaccines in Africa.非洲口服霍乱疫苗的分配
Vaccines (Basel). 2025 May 14;13(5):519. doi: 10.3390/vaccines13050519.
2
Impact of a multi-pronged cholera intervention in an endemic setting.多管齐下的霍乱干预措施在地方病流行地区的影响。
PLoS Negl Trop Dis. 2025 Feb 19;19(2):e0012867. doi: 10.1371/journal.pntd.0012867. eCollection 2025 Feb.
3
Impact of a multi-pronged cholera intervention in an endemic setting.多管齐下的霍乱干预措施在地方病流行地区的影响。

本文引用的文献

1
Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination.优化 COVID-19 疫苗的分配显示了单剂疫苗接种的潜在作用。
Nat Commun. 2021 Jun 8;12(1):3449. doi: 10.1038/s41467-021-23761-1.
2
Protection afforded by previous Vibrio cholerae infection against subsequent disease and infection: A review.先前感染霍乱弧菌对随后疾病和感染的保护作用:综述。
PLoS Negl Trop Dis. 2021 May 20;15(5):e0009383. doi: 10.1371/journal.pntd.0009383. eCollection 2021 May.
3
Refugee Settlements and Cholera Risks in Uganda, 2016-2019.
medRxiv. 2024 Sep 9:2023.12.14.23299970. doi: 10.1101/2023.12.14.23299970.
4
Comprehensive Review on the Use of Oral Cholera Vaccine (OCV) in Ethiopia: 2019 to 2023.埃塞俄比亚口服霍乱疫苗(OCV)使用情况的综合综述:2019 年至 2023 年。
Clin Infect Dis. 2024 Jul 12;79(Supplement_1):S20-S32. doi: 10.1093/cid/ciae194.
5
Cholera rages in Africa and the Middle East: A narrative review on challenges and solutions.霍乱在非洲和中东肆虐:关于挑战与解决方案的叙述性综述
Health Sci Rep. 2024 May 12;7(5):e2013. doi: 10.1002/hsr2.2013. eCollection 2024 May.
6
Informing policy via dynamic models: Cholera in Haiti.通过动态模型为政策提供信息:海地的霍乱疫情。
PLoS Comput Biol. 2024 Apr 29;20(4):e1012032. doi: 10.1371/journal.pcbi.1012032. eCollection 2024 Apr.
7
Comparison of the immunogenicity and safety of Euvichol-Plus with Shanchol in healthy Indian adults and children: an open-label, randomised, multicentre, non-inferiority, parallel-group, phase 3 trial.在健康的印度成人和儿童中比较Euvichol-Plus与Shanchol的免疫原性和安全性:一项开放标签、随机、多中心、非劣效性、平行组3期试验。
Lancet Reg Health Southeast Asia. 2023 Aug 24;19:100256. doi: 10.1016/j.lansea.2023.100256. eCollection 2023 Dec.
8
Targeted randomization dose optimization trials enable fractional dosing of scarce drugs.靶向随机化剂量优化试验可实现稀缺药物的分数剂量给药。
PLoS One. 2023 Oct 30;18(10):e0287511. doi: 10.1371/journal.pone.0287511. eCollection 2023.
9
Optimizing two-dose vaccine resource allocation to combat a pandemic in the context of limited supply: The case of COVID-19.优化两剂疫苗资源分配以应对有限供应情况下的大流行:以 COVID-19 为例。
Front Public Health. 2023 Apr 24;11:1129183. doi: 10.3389/fpubh.2023.1129183. eCollection 2023.
10
Evaluation of mpox vaccine dose-sparing strategies.猴痘疫苗剂量节省策略评估。
PNAS Nexus. 2023 Mar 28;2(5):pgad095. doi: 10.1093/pnasnexus/pgad095. eCollection 2023 May.
2016-2019 年乌干达难民营与霍乱风险。
Am J Trop Med Hyg. 2021 Feb 8;104(4):1225-1231. doi: 10.4269/ajtmh.20-0741.
4
Vaccine optimization for COVID-19: Who to vaccinate first?2019冠状病毒病疫苗优化:优先接种对象为谁?
Sci Adv. 2021 Feb 3;7(6). doi: 10.1126/sciadv.abf1374. Print 2020 Feb.
5
Achieving coordinated national immunity and cholera elimination in Haiti through vaccination: a modelling study.通过疫苗接种实现海地全国免疫协调和消除霍乱:建模研究。
Lancet Glob Health. 2020 Aug;8(8):e1081-e1089. doi: 10.1016/S2214-109X(20)30310-7.
6
Infectious disease outbreaks among forcibly displaced persons: an analysis of ProMED reports 1996-2016.流离失所者中的传染病暴发:对1996 - 2016年国际传染病预警组织报告的分析
Confl Health. 2020 Jul 22;14:49. doi: 10.1186/s13031-020-00295-9. eCollection 2020.
7
Oral cholera vaccination coverage in an acute emergency setting in Somalia, 2017.2017 年索马里急性紧急情况下的口服霍乱疫苗接种覆盖率。
Vaccine. 2020 Feb 29;38 Suppl 1:A141-A147. doi: 10.1016/j.vaccine.2020.01.015. Epub 2020 Jan 21.
8
Comparing alternative cholera vaccination strategies in Maela refugee camp: using a transmission model in public health practice.比较 Maela 难民营中替代霍乱疫苗接种策略:在公共卫生实践中使用传播模型。
BMC Infect Dis. 2019 Dec 21;19(1):1075. doi: 10.1186/s12879-019-4688-6.
9
Global oral cholera vaccine use, 2013-2018.全球口服霍乱疫苗使用情况,2013-2018 年。
Vaccine. 2020 Feb 29;38 Suppl 1(Suppl 1):A132-A140. doi: 10.1016/j.vaccine.2019.08.086. Epub 2019 Sep 10.
10
Epidemiology of cholera.霍乱流行病学
Vaccine. 2020 Feb 29;38 Suppl 1:A31-A40. doi: 10.1016/j.vaccine.2019.07.078. Epub 2019 Aug 5.